<a href="https://cancerworld.net/e-grandround/obesity-and-cancer/" title="Obesity and cancer"> Obesity and cancer

How to become the best cancer doctor you can be

If your ambition is to excel at the oncology career you have chosen, you have to find your own pathway to success. Anna Wagstaff talked to three early-career oncologists who are trying to do just [more]
Is precision medicine ignoring people dying of cancer?

While we’re pouring resources into learning what keeps cancer cells alive, with the aim of blocking their supply lines, there is next to no interest in the molecular pathways that end up choking the life [more]
Maria Nazinkina Del Grande: bridging two worlds

A daughter and granddaughter of Russian heads of radiology, now living and working in southern Switzerland, medical oncologist Maria Nazinkina Del Grande is keen to play a part in bringing her two worlds closer together. [more]
The future is digital – but is it safe?

Joined-up patient-centred care requires sharing of data between patients, oncologists, hospitals, labs, GPs, nurses and even social care. But as apps designed to gather and share this data proliferate, so does the risk that the [more]
NETs – Why this master of disguise needs careful handling

Rare, hard to recognise, with primaries occurring at many different sites and associated with a wide variety of symptoms, tumours of the neuroendocrine system (NETs) are often detected too late to cure, and can be [more]
Obesity and cancer

Obesity is overtaking tobacco as the leading preventable cause of cancer. Oncologists have an important role to play in informing patients and directing them towards assistance in making lifestyle changes. Antonio Di Meglio reviews the [more]
Surviving in the workplace: Why it’s so hard and how we can make it easier

Working lives can be an important part of who we are, and many of us also need to work for financial reasons. Yet cancer survivors often have to struggle to get their working lives back [more]
The body after treatment: Do we do enough to protect our patients’ self-image?

Studies indicate that a significant proportion of patients live to regret saying ‘yes’ to cancer treatments because of the impact on how they look, function or feel. Simon Crompton talks to patients and physicians about [more]
Real world evidence: why we patients need it, and how we can get it

Roger Wilson is a leading voice in cancer patient advocacy. He has been living with a recurrent sarcoma for 20 years, and is a co-founder of Sarcoma Patients Euronet. He is on the faculty of [more]
How to nurse hope in recurrent ovarian cancer

Results from studies on PARP inhibitors show that BRCA status and responsiveness to platinum analogues are much less binding that it was thought to achieve some improvements. But more clinical trials are needed to decide if PARP inhibitors should be used as part of first-line therapy or reserved for a later line [more]